Suchergebnisse - "Pérez-de-Llano, Luis"

PubPharm (147)

41

Factors Associated to Hospital Admission in a Care Protocol in COVID-19

enthalten in: Archivos de bronconeumologia | 2020

von Golpe, R. | Blanco, N. | Castro-Añón, O. | +7

42

Hospital Epidemics Tracker (HEpiTracker) : Description and pilot study of a mobile app to track COVID-19 in hospital workers

enthalten in: JMIR public health and surveillance | 2020

von Soriano, J. | Fernández, E. | de Astorza, �. | +22

43

Regarding the role of F ENO in predicting failure after ICS reduction in mild-to-moderate asthma patients

enthalten in: The European respiratory journal | 2020

von Pérez de Llano, L. | Blanco Cid, N. | Martin Robles, I. | +3

CommentOn: Eur Respir J. 2020 May 21;55(5):. - PMID 32139458

44

International severe asthma registry (ISAR) : protocol for a global registry

enthalten in: BMC medical research methodology | 2020

von FitzGerald, J. | Tran, T. | Alacqua, M. | +45

45

International severe asthma registry (ISAR): protocol for a global registry

enthalten in: BMC medical research methodology | 2020

von FitzGerald, J. | Tran, T. | Alacqua, M. | +45

46

International severe asthma registry (ISAR): protocol for a global registry

enthalten in: BMC medical research methodology | 2020

von FitzGerald, J. | Tran, T. | Alacqua, M. | +45

47

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

enthalten in: Allergy | 2020

von Agache, I. | Beltran, J. | Akdis, C. | +31

48

The Effect of Hospital Discharge with Empiric Noninvasive Ventilation on Mortality in Hospitalized Patients with Obesity Hypoventilation Syndrome. An Individual Patient Data Meta-Analysis

enthalten in: Annals of the American Thoracic Society | 2020

von Mokhlesi, B. | Masa, J. | Afshar, M. | +21

49

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma : A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

enthalten in: Allergy | 2020

von Agache, I. | Rocha, C. | Beltran, J. | +31

50

Efficacy and safety of treatment with dupilumab for severe asthma : A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma

enthalten in: Allergy | 2020

von Agache, I. | Song, Y. | Rocha, C. | +31